Alembic Pharmaceuticals Limited — Updates, 09-09-2025: Press Release
09-09-2025 | 10:50 am
09-09-2025 | 10:50 am
Alembic Pharma secures USFDA Final Approval for Phytonadione Injectable Emulsion, targeting a US$ 44 million market. This adds to its 225 cumulative ANDA approvals, strengthening its US generics portfolio.
No comments yet. Be the first to comment!
